186 related articles for article (PubMed ID: 25281926)
1. Involvement of lysosomal degradation in VEGF-C-induced down-regulation of VEGFR-3.
Han KY; Chang JH; Dugas-Ford J; Alexander JS; Azar DT
FEBS Lett; 2014 Nov; 588(23):4357-63. PubMed ID: 25281926
[TBL] [Abstract][Full Text] [Related]
2. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
3. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
4. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.
Li J; Chen Y; Zhang L; Xing L; Xu H; Wang Y; Shi Q; Liang Q
J Ethnopharmacol; 2016 Dec; 193():293-302. PubMed ID: 27553977
[TBL] [Abstract][Full Text] [Related]
5. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
6. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
7. VEGFR-3 signaling is regulated by a G-protein activator, activator of G-protein signaling 8, in lymphatic endothelial cells.
Sakima M; Hayashi H; Mamun AA; Sato M
Exp Cell Res; 2018 Jul; 368(1):13-23. PubMed ID: 29649427
[TBL] [Abstract][Full Text] [Related]
8. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells.
Huang YH; Yang HY; Huang SW; Ou G; Hsu YF; Hsu MJ
PLoS One; 2016; 11(7):e0158839. PubMed ID: 27383632
[TBL] [Abstract][Full Text] [Related]
10. VEGF and thrombin induce MKP-1 through distinct signaling pathways: role for MKP-1 in endothelial cell migration.
Kinney CM; Chandrasekharan UM; Mavrakis L; DiCorleto PE
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C241-50. PubMed ID: 18003751
[TBL] [Abstract][Full Text] [Related]
11. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.
Tammela T; Zarkada G; Nurmi H; Jakobsson L; Heinolainen K; Tvorogov D; Zheng W; Franco CA; Murtomäki A; Aranda E; Miura N; Ylä-Herttuala S; Fruttiger M; Mäkinen T; Eichmann A; Pollard JW; Gerhardt H; Alitalo K
Nat Cell Biol; 2011 Sep; 13(10):1202-13. PubMed ID: 21909098
[TBL] [Abstract][Full Text] [Related]
12. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands.
Chung ES; Chauhan SK; Jin Y; Nakao S; Hafezi-Moghadam A; van Rooijen N; Zhang Q; Chen L; Dana R
Am J Pathol; 2009 Nov; 175(5):1984-92. PubMed ID: 19808642
[TBL] [Abstract][Full Text] [Related]
13. CD34+ VEGFR-3+ progenitor cells have a potential to differentiate towards lymphatic endothelial cells.
Tan YZ; Wang HJ; Zhang MH; Quan Z; Li T; He QZ
J Cell Mol Med; 2014 Mar; 18(3):422-33. PubMed ID: 24450475
[TBL] [Abstract][Full Text] [Related]
14. Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites.
Dixelius J; Makinen T; Wirzenius M; Karkkainen MJ; Wernstedt C; Alitalo K; Claesson-Welsh L
J Biol Chem; 2003 Oct; 278(42):40973-9. PubMed ID: 12881528
[TBL] [Abstract][Full Text] [Related]
15. Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis.
Kajiya K; Sawane M; Huggenberger R; Detmar M
J Invest Dermatol; 2009 May; 129(5):1292-8. PubMed ID: 19005491
[TBL] [Abstract][Full Text] [Related]
16. VEGF-C alters barrier function of cultured lymphatic endothelial cells through a VEGFR-3-dependent mechanism.
Breslin JW; Yuan SY; Wu MH
Lymphat Res Biol; 2007; 5(2):105-13. PubMed ID: 17935478
[TBL] [Abstract][Full Text] [Related]
17. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
[TBL] [Abstract][Full Text] [Related]
18. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
19. CD146 is required for VEGF-C-induced lymphatic sprouting during lymphangiogenesis.
Yan H; Zhang C; Wang Z; Tu T; Duan H; Luo Y; Feng J; Liu F; Yan X
Sci Rep; 2017 Aug; 7(1):7442. PubMed ID: 28785085
[TBL] [Abstract][Full Text] [Related]
20. Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway.
Yu J; Zhang X; Kuzontkoski PM; Jiang S; Zhu W; Li DY; Groopman JE
Cell Commun Signal; 2014 Apr; 12():25. PubMed ID: 24708522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]